Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

NYSE:PFE - Post Discussion

Pfizer Inc > Pfizer set to file FDA application for vaccine today
View:
Post by Humanist on Nov 20, 2020 8:33am

Pfizer set to file FDA application for vaccine today

Pfizer set to file FDA application for vaccine today
Nov. 20, 2020 3:40 AM ET

Pfizer Inc. (PFE)By: Yoel Minkoff, SA News Editor16 Comments

  • There's a lot to digest on the COVID front.
  •  
  • Pfizer (NYSE:PFE) intends to file an application to the FDA for emergency use of its coronavirus vaccine today, according to Health and Human Services Secretary Alex Azar, with Moderna (NASDAQ:MRNA) soon to follow.
  •  
  • Earlier this week, Azar said there will be roughly 40M doses of vaccine available by the end of this year between the two companies, enough to inoculate about 20M people.
  •  
  • Both vaccines have shown about 95% efficacy rates in late stage trials and are seen by investors and policymakers as a solution to get the economy going again.
Comment by NSPfacts on Nov 20, 2020 12:20pm
This post has been removed in accordance with Community Policy
Comment by NSPfacts on Nov 20, 2020 2:27pm
This post has been removed in accordance with Community Policy
Comment by NSPfacts on Nov 20, 2020 3:34pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities